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Members of the Dairy Team at Kansas State University are pleased to present the 2014 
Dairy Research Report of Progress. Dairying continues to contribute significantly to 
the agricultural economy of Kansas. In 2012, dairy farms accounted for 3.6%, or $541 
million, of all Kansas farm receipts, ranking 7th overall among all Kansas farm com-
modities. The Kansas dairy industry is growing, ranking number 1 nationally with an 
increase of 8,000 cows from 2012 to 2013. During the past 5 years (2008 to 2013), total 
milk production in Kansas has increased by 21.4%; the number of cows by 14.5%; and 
pounds of milk per cow by 1,240. At the end of 2013, Kansas ranked 13th nationally in 
milk yield per cow at 21,881 lb, 16th in the number of dairy cows (134,000), and 16th 
in total milk production (2.93 billion lb). Kansas now has 325 dairy operations and 
averages 412 cows per herd (Hoard’s Dairyman, March 25, 2014, pp. 212-213).
Selected production traits of our Kansas State University Dairy Teaching and Research 
Center (DTRC) herd are shown below. With the pressures of research and an aging 
facility, we shifted most of the herd to twice daily milking in August 2014, but we re-
main pleased with our production. The excellent functioning of our herd is a tribute to 
the dedication of our staff: Michael Scheffel (manager), Daniel Umscheid, Robert Fiest, 
Alan Hubbard, Kris Frey, and Eulises Jiron Corrales. Special thanks are given to Col-
leen Hill, Cheryl Armendariz, and a host of graduate and undergraduate students for 
their technical assistance in our laboratories and at the DTRC. We also acknowledge 
the support and cooperation of the Heart of America DHIA laboratory here in Man-
hattan, KS, for its assistance in handling research milk samples. 
Kansas State University Dairy Teaching and Research Center Herd1
Cows, total no. 312
Rolling herd milk, lb 31,890
Rolling herd fat, lb 1,076
Rolling herd protein, lb 941
Somatic cell count × 1,000 157
Calving interval, mo. 12.9 
1 October 8 test day (milking 2 to 3 times daily; no bST).
The sustained increases in productivity and efficiency on dairy farms in Kansas and 
across the U.S. are largely driven by improved technology and management decisions by 
dairymen. It is our hope that the type of research presented in this report contributes 
to those improvements. We recognize and thank Dr. Jeffrey Stevenson for his time and 
expertise in editing the previous 30+ annual dairy research reports; his impact has been 
tremendous.
III
Thorough, quality research is not only time-intensive and meticulous, but also expen-
sive. Nevertheless, studies have demonstrated that each dollar spent for research yields a 
30 to 50% return in practical application. Those interested in supporting dairy research 
are encouraged to consider participation in the Livestock and Meat Industry Council 
(LMIC), a philanthropic organization dedicated to furthering academic and research 
pursuits by the Department of Animal Sciences and Industry. Additional details about 
the LMIC are found at the end of this report.
B. J. Bradford, Editor 
2014 Dairy Research Report of Progress
IV
Biological Variability and Chances of Error
Variability among individual animals in an experiment leads to problems in interpret-
ing the results. Although cows on treatment X may have produced more milk than 
those on treatment Y, variability within treatments may indicate that the differences in 
production between X and Y were not the direct result of treatment alone. Statistical 
analysis allows us to calculate the probability that such differences occur because of the 
treatment applied rather than from chance.
In some of the articles herein, you will see the notation “P < 0.05.” That means the 
probability of treatment differences resulting from chance is less than 5%. If two aver-
ages are reported to be “significantly different,” the probability is less than 5% that the 
difference is from chance, or the probability exceeds 95% that the difference resulted 
from the treatment applied.
Some papers report correlations or measures of the relationship among traits. The rela-
tionship may be positive (both traits tend to get larger or smaller together) or negative 
(as one trait gets larger, the other gets smaller). A perfect correlation is one (+1 or -1). If 
there is no relationship, the correlation is zero.
In other papers, you may see an average given as 2.5 ± 0.1. The 2.5 is the average; 0.1 is 
the “standard error.” The standard error is calculated to be 68% certain that the real av-
erage (with an unlimited number of animals) would fall within one standard error from 
the average, in this case between 2.4 and 2.6.
Using many animals per treatment, replicating treatments several times, and using 
uniform animals increase the probability of finding real differences when they exist. Sta-
tistical analysis allows more valid interpretation of the results, regardless of the number 
of animals in the experiment. In all the research reported herein, statistical analyses are 
included to increase the confidence you can place in the results.
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Effects of Milk, Pasteurized Milk, and Milk 
Replacer on Health and Productivity of Dairy 
Calves
L. Hulbert, S. Trombetta, J. Noel, S. Moisá, S. Montgomery, G. Hanzlicek,  
and B. Bradford
Summary
Our objectives were to determine the health and blood parameters before, during, and 
after weaning of 114 Holstein heifers fed either accelerated milk replacer (MR; 28% 
CP, 18% fat) or non-saleable milk (3.59 ± 0.28% true protein; 4.12 ± 0.37% fat) that 
was either pasteurized (PM) or raw (RM; refrigerated and fed <24 h after collection). 
Calves were randomly assigned to feeding treatments at birth. Colostrum (1 L) was fed 
less than 14 hours after birth (MR and PM = pasteurized colostrum; RM = raw colos-
trum). All calves were bottle-fed 1.8 ± 0.20 L, 3 times daily; all calves were provided 
fresh water and grain ad libitum throughout the experiment. Calves began step-down 
weaning at age 5 weeks and completed weaning at age 6 weeks. Blood samples were col-
lected at ages 3, 5, and 7 weeks and were analyzed for complete blood counts (CBC) us-
ing a Procyte Idexx Analyzer (IDEXX Laboratories, Inc., Westbrook, ME). Fecal scores 
were observed twice daily, on a 1 to 3 scale (FS1 = normal, FS2 = loose, FS3 = scours). 
Results showed that MR-fed calves had more (P < 0.01) observations (%obs) with  
FS > 2 than the PM- and RM-fed calves (2.3 vs. 1.6 and 1.7 ± 0.2 %obs, respectively). 
In addition, there were no differences in body weight or shoulder or hip height between 
treatments, but a treatment × week interaction (P = 0.05) occurred for grain con-
sumed, with a noticeably higher increase between 6 and 7 weeks of age for MR calves. 
When CBC was considered, there were no differences in blood cell types, but MR-fed 
calves had greater mean corpuscular volume (MCV) than the other calves (P < 0.01), 
leading to higher resistance for iron deficiency anemia. In conclusion, these findings 
suggest that calf performance and feed intake are not affected by the administration of 
raw milk, pasteurized milk, or milk replacer. Moreover, CBC health parameters showed 
no significant changes due to administration of the different types of milk sources. 
Key words: milk replacer, pasteurization, calves, hematology, fecal score
Introduction
It has become increasingly common for dairy producers to utilize non-saleable milk for 
feeding calves. This practice has been less common on small dairies, which sometimes 
struggle with variability in the supply of non-saleable milk and lack the scale to afford 
high-throughput pasteurization systems, but smaller-scale pasteurization systems are 
now available and are becoming more widely used on relatively small dairies.
Some research has been conducted to evaluate the effects of using pasteurized non-sale-
able milk to feed calves. Efficacy of pasteurization (i.e., reduction in bacteria load) has 
been tested on numerous commercial dairies, and results generally have been favorable 
when protocols were followed carefully. Several studies have demonstrated increased 
growth rates for calves fed milk compared with those fed milk replacer, even when 
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fat, protein, and lactose concentrations were nearly equal between the milk and milk 
replacer1. However, many calf experts now recommend “accelerated” feeding programs 
based on the utilization of milk replacers with more protein than fat (often 28% pro-
tein, 18 to 20% fat on a dry basis). To our knowledge, no university studies have been 
conducted to compare the performance of dairy heifers fed these newer-generation milk 
replacers compared with those fed milk. 
Experimental Procedures
Heifers born at the Kansas State University Dairy Teaching and Research Center 
during a 12-month period were enrolled in a randomized complete block design study. 
Heifers with birth weights <60 lb and those born with calving scores >2 were excluded 
from the study; approximately 114 heifers were enrolled prior to this analysis. After 
receiving colostrum twice in the first 14 hours after birth (MR and PM = pasteur-
ized colostrum; RM = raw colostrum), calves were randomly assigned to one of three 
treatments: raw milk (RM), pasteurized milk (PM), or milk replacer (MR). Milk used 
for RM and PM came from the non-saleable milk supply at the dairy, and MR was 
Mother’s Pride (Hubbard Feeds, Mankato, MN), which contains 28% protein and 18% 
fat on a DM basis and was mixed per label directions to achieve 14.2% total solids. This 
formulation provides the same metabolizable energy per unit of volume as milk; there-
fore, treatments were fed on an equal-volume basis. From a macronutrient perspective, 
treatments differed primarily in protein supply. Calves were fed 3 times daily: 3 pints 
per feeding for calves <80 lb and 4 pints per feeding for calves >80 lb. Heifers were 
housed individually in hutches and milk/MR and starter intake was recorded daily. 
Heifers were weaned no earlier than 6 weeks of age and continued to receive treatment 
milk/MR until they consumed at least 2 lb of starter for 3 consecutive days. Intakes 
were recorded through weaning, although the study formally ended at 6 weeks of age. 
After weaning, all calves were managed uniformly.
Samples of all treatment milk/MR were collected once weekly for nutrient analysis, 
and pre-/post-pasteurization PM samples were collected for total bacterial counts on 
these days. Fecal scores were recorded twice daily on a 1 to 3 scale (FS1 = normal, FS2 
= loose, FS3 = scours) to assess gastrointestinal health, and all diseases and treatments 
were recorded. Body weights and hip and shoulder heights were recorded weekly at 
birth until 24 weeks of age. 
Statistical analysis was conducted using mixed effects models to assess treatment effects 
on blood cell profiles, the proportion of observations with abnormal fecal scores, body 
weight, hip height, shoulder height, milk/MR intake, and starter intake. Fixed effects 
were treatment, week, and treatment × week interaction. Calf nested within treatment 
was the random effect. 
Results
Calf growth results showed only a week effect on body weight and hip and shoulder 
height, with no differences due to feeding raw milk, pasteurized milk, or milk replacer 
(Figure 1).
1 Lee et al. 2009. Influence of equalizing the gross composition of milk replacer to that of whole milk on 
the performance of Holstein calves. J. Anim. Sci. 87:1129–1137. 
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Mean Corpuscular Volume (MCV) was the only hematological value that was af-
fected by treatment × week interaction (Table 1). No treatment effect was detected 
on blood cell type percentages related to immune response (neutrophils, monocytes, 
lymphocytes, etc.). These blood cell types were affected by week, with a decrease in 
percentage for neutrophils over time and increases in the proportions of monocytes and 
lymphocytes (Table 1). In contrast, there was a treatment effect with higher numbers 
for hemoglobin (HGB), hematocrit (HCT), MCV, and Eosinophils for MR-calves 
and lower values for MR-calves compared with other treatments for mean corpuscular 
hemoglobin concentration (MCHC), red cell distribution width (RDW), and platelets 
count (PLT).
Grain consumed was affected by a treatment × week interaction (P = 0.05), with dif-
ferences mainly due to a week effect with a more dramatic increase in grain consumed 
from 6 to 7 weeks of age in MR calves (Figure 2).
The proportion of fecal scores higher than 2 on the 1 to 3 scale is presented in Figure 
3 as percentage of total observations (twice daily). Results showed that calves that 
received milk replacer had more frequent occurrence of diarrhea than calves fed with 
pasteurized milk or raw milk (P = 0.003).
Discussion
Different treatments did not affect the growth performance of the calves. Calves grew at 
a similar rate, with no differences in height between animals fed milk or milk replacer; 
moreover, intake behavior increased exponentially after 6 weeks of age for all treat-
ments. These results fail to demonstrate any advantage of the additional preweaning 
protein intake in the MR group. 
The MCV is a measure of the average volume of red blood cells. The measure is ob-
tained by multiplying a volume of blood by the proportion of blood that is cellular 
(HCT) and dividing that product by the number of erythrocytes (red blood cells) in 
that volume. MCV measurement allows classification of the different types of anemia. 
Our results showed that milk replacer-fed calves had higher MCV values compared 
with other treatments for all time points analyzed, with treatment affecting parameters 
that determine absence of anemia such as higher hemoglobin, higher hematocrit, and 
higher main corpuscular volume for MR-calves, suggesting that milk replacer-fed calves 
might be receiving higher amounts of iron through the fortified trace minerals complex 
of the milk replacer, which leads to an animal less prone to suffer iron deficiency type of 
anemia (microcytic anemia). Across species, iron is among the most limiting nutrients 
in milk when consumed as a complete diet. 
It was previously established that feeding milk replacer may increase fecal scores in 
preweaned calves, particularly within the first 2 weeks of life. Presence of diarrhea might 
lead to dehydration that produces a falsely high hematocrit that disappears when proper 
fluid balance is restored. Our results were consistent with these observations (Figure 4), 
which might be related to the difference in protein content between milk replacer and 




These results failed to provide any evidence of differences in heifer calf growth and feed 
intake in response to feeding milk replacer or non-saleable milk that is raw or pasteur-
ized. Milk replacer-fed calves might be less prone to iron deficiency anemia based on 
mean corpuscular volume. However, milk replacer-fed calves had a higher proportion of 
loose fecal scores, suggesting that the higher protein content increased the visual appear-
ance of diarrhea.
In conclusion, if managers must choose between the use of a milk replacer or non-sale-
able milk based on the results of this study, they might have a hard time trying to take a 
decision due to the slight differences perceived in terms of calves’ performance and their 











































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 1. Body weight and shoulder and hip height for calves that received milk replac-
er, pasteurized milk, and raw milk. Treatments were fed from birth through weaning 
(6 weeks), and growth was monitored until 24 weeks of age. 
P-value < 0.05: * treatment effect, ** week effect, *** treatment × week effect. 





























Figure 2. Grain consumed for calves that received milk replacer, pasteurized milk, and raw 
milk. Starter intake was recorded daily from birth until all calves were weaned (8 weeks of 
age). 
P-value < 0.05: * treatment effect, ** week effect, *** treatment × week effect. SEM = 0.61. 






















Figure 3. Percentage of observed fecal score higher than 2 on a 1 to 3 scale (FS1 = normal, 
FS2 = loose, FS3 = scours). Diarrhea appearance was observed twice daily in calves that 
received milk replacer, pasteurized milk, and raw milk. 



























































Figure 4. Percentage of hematocrit and mean corpuscular volume at 3, 5, and 7 weeks of 
age in calves that received milk replacer, pasteurized milk, and raw milk. 
Means denoted by different letters differed at P < 0.05. * treatment effect, ** week effect,  
*** treatment × week effect.
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Yeast Product Supplementation Influences Feeding 
Behavior and Measures of Immune Function  
in Transition Dairy Cows
 
K. Yuan, M. Muckey, L. Mendonça, L. Hulbert, and B. Bradford
Summary
Yeast supplementation has been shown to increase feed intake and production in 
some studies with early lactation dairy cows, but the mechanisms underlying this effect 
remain unknown. The objective of this study was to assess the effects of supplementing 
a yeast product derived from Saccharomyces cerevisiae on production, feeding behavior, 
and immune function in cows during the transition to lactation. When fed for 3 weeks 
before calving through 6 weeks after calving, supplementation altered feeding behavior 
as well as responsiveness to vaccination and gut immunoglobulin secretion. Results sug-
gest that yeast products can modulate several aspects of immune function and promote 
the consumption of smaller, more frequent meals.
Key words: transition dairy cow, yeast, nutrition, immunity
Introduction
The 2 weeks after calving remain the most challenging window of time during the dairy 
production cycle, often accounting for more than 50% of total disease in the lactating 
herd. The health challenges at this time include both metabolic and infectious diseases, 
resulting in a complex problem, often without any obvious cause. Our current under-
standing of transition cows suggests that rapid weight loss caused by low feed intake as 
well as poor immune function during this time combine to lead to these health prob-
lems.
Relatively strong evidence indicates that dietary yeast culture can increase DMI in early 
lactation, and more recent evidence suggests that this can happen through alterations 
in meal patterns. Furthermore, many studies in model organisms and young ruminants 
have suggested that yeast products can alter numerous functions of the immune system. 
In light of the immunosuppression that occurs during the transition period, there is 
great interest in the use of a yeast product to enhance immune function during this 
time when mammary and uterine infections are such a challenge. Our objective was to 
determine whether supplementing a yeast product derived from Saccharomyces cerevisi-
ae altered production, feeding behavior, and measures of immune function in transition 
cows.
Experimental Procedures
Forty multiparous Holstein cows were blocked by expected calving date and randomly 
assigned within block to 1 of 4 treatments (10 cows per treatment) from 21 days before 
expected calving to 42 days postpartum. Rations were top-dressed with yeast culture 
plus enzymatically hydrolyzed yeast (YC-EHY; Celmanax, Vi-COR, Mason City, IA) 
at the rate of 0, 30, 60, or 90 g/day throughout the experiment. The basal diets fed pre-
10
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partum and postpartum are detailed in Table 1. Dry matter and water intake, feeding 
behavior, and milk production were monitored daily throughout the study.
To evaluate humoral immune function, cows were challenged (subcutaneous injection) 
with 1 mg of ovalbumin (OVA; Sigma-Aldrich, St. Louis, MO) diluted in vaccine adju-
vant (VET-SAP, Desert King International, San Diego, CA; 0.5 mg of adjuvant dis-
solved in 1 mL of saline) on days -21, -7, and 14. Blood samples were collected on days 
-21, 14, and 21 relative to calving from the coccygeal vessels 1 hour prior to feeding for 
determination of antibody titer against OVA. To evaluate mucosal immune function, 
fecal samples were collected on days 7 and 21 of lactation for analysis of immunoglobu-
lin A (IgA) concentration.
To evaluate the efficiency of net energy utilization for milk production, energy supplied 
by the diet and body condition mobilization were estimated. Energy utilization efficien-
cy was then quantified as milk energy output / (diet energy supply + energy from body 
condition mobilization).
One cow in the 0 g/day treatment group was removed from the study on day 30 post-
partum due to difficulty standing up in the tie-stall. Data obtained from this cow prior 
to removal were included in all analyses. Feeding behavior variables were calculated 
from logged data that included the start and end weights as well as start and end times 
of meals, and meals were combined if the intermeal interval was less than 12 minutes. 
Data were analyzed using mixed models with repeated measures over time. Models in-
cluded the fixed effects of treatment, time, and their interaction, and the random effect 
of cow. Contrast statements were used to assess the overall effect of YC-EHY (control 
vs. all YC-EHY treatments) as well as the linear and quadratic effects of dose. Signifi-
cance was declared at P ≤ 0.05 and tendencies at 0.05 < P ≤ 0.10.
Results
Pre- and postpartum DMI and water intake did not differ (P > 0.10) among treatments 
(Table 2). Quadratic dose effects (P < 0.05) were detected for prepartum feeding behav-
ior, reflecting decreased meal size and increased meal frequency for cows that received 
30 and 60 g/day of YC-EHY. Postpartum feeding behavior and milk yield were unaf-
fected (P > 0.10) by treatments, but tendencies for increased (P ≤ 0.10) percentages of 
milk fat, protein, and lactose were detected for cows receiving YC-EHY (Table 3). Fur-
thermore, YC-EHY tended to increase the proportion of total energy supply secreted in 
milk nutrients (P ≤ 0.10; Table 3).
Increasing YC-EHY dose linearly increased (P < 0.01) plasma anti-ovalbumin IgG lev-
els following 3 ovalbumin challenges (Figure 1A), suggesting that treatments enhanced 
humoral immunity. Increasing YC-EHY dose also quadratically increased fecal IgA 
concentrations in early lactation (P = 0.03; Figure 1B), suggesting that 30 and 60 g/day 
doses enhanced mucosal immunity.
Discussion
These results provide some intriguing evidence that YC-EHY shifts meal patterns 
and results in cows eating smaller, more frequent meals. Although this was found to 
be significant only prepartum, numerical patterns during the postpartum period were 
11
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similar. Smaller, more frequent meals may be beneficial from the standpoint of main-
taining stable ruminal conditions, because very large meals provide a lot of fermentable 
substrate and can result in decreased ruminal pH, at least for a short period of time. We 
found no evidence, however, that YC-EHY increases DMI in the critical first 6 weeks 
after parturition. 
By accounting for energy derived from release of stored tissue (i.e., body fat), we found 
that YC-EHY tended to improve efficiency of energy utilization for milk production. 
Substantial evidence in past studies indicates that yeast products can improve diet 
digestibility in ruminants. Although we did not directly measure this, the tendency for 
increased energy efficiency with YC-EHY in our study is consistent with an increase in 
diet digestibility.
We found that YC-EHY increased antibody production following vaccination against 
OVA and, at intermediate doses, increased gastrointestinal IgA release. Humoral im-
munity (antibody-based protection) is thought to be suppressed during the transition 
to lactation, so the ability of a feed additive to enhance this capacity is encouraging. 
Secretion of IgA by mucosal immune cells lining the gut is one key mechanism that 
helps prevent attachment of gut pathogens to the epithelium, thereby minimizing gas-
trointestinal disease. These findings are interesting, but whether or not a feed additive 
limits the risk of infection or speeds recovery from infection must be tested in disease 
challenge studies or large-scale studies capable of assessing health risks.
Conclusions
Feeding a yeast culture product with enzymatically hydrolyzed yeast did not affect milk 
production or DMI during the transition to lactation but modulated feeding behavior 
and several aspects of immunity. In the current study, a 60 g/day dose of YC-EHY 
resulted in favorable changes in feeding behavior, mucosal and humoral immunity, and 
supported the numerically greatest energy efficiency and milk yield postpartum. Fu-
ture studies with larger numbers of animals may provide more insight into production 
implications of these biological responses.
12
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Table 1. Ingredient and nutrient composition of diets
Item Prepartum Postpartum
Ingredient, % of DM
Corn silage 29.5 15.9
Wet corn gluten feed 21.3 34.3
Alfalfa hay - 14.2
Wheat straw 10.9 3.3
Prairie hay 16.8 -
Cottonseed - 5.0
Ground corn 3.4 11.2
Dry-rolled sorghum grain 3.4 6.4
Mechanically extracted soybean meal 12.3 4.8
Molasses 1.2 1.2
Ca salts of long-chain fatty acids - 0.8
Micronutrient premix 1.3 2.9
Nutrient, % of DM










Table 2. Feed and water intake and feeding behavior responses to yeast culture-enzymatically hydrolyzed yeast 
(YC-EHY) supplementation during the experimental period
Treatment (YC-EHY dose/day) P-value








DMI, kg/day 12.1 11.9 12.6 12.1 0.51 0.86 0.77 0.76
Water intake, L/day 49.0 48.3 49.0 51.3 2.38 0.84 0.48 0.53
Meal frequency, per day 10.1 11.4 11.2 10.0 0.45 0.12 0.80 0.01
Intermeal interval, hours 2.08 1.87 1.94 2.08 0.08 0.18 0.86 0.02
Meal size, kg DM 1.23 1.06 1.16 1.24 0.06 0.27 0.68 0.04
Meal length, minutes 20.6 17.7 17.3 21.1 1.58 0.31 0.87 0.04
Postpartum measures
DMI, kg/day 21.8 19.7 21.5 22.8 1.13 0.73 0.34 0.14
Water intake, L/day 105.6 96.1 105.6 105.2 5.15 0.59 0.72 0.40
Meal frequency, per day 12.8 13.1 13.5 12.2 0.62 0.85 0.62 0.19
Intermeal interval, hours 1.50 1.50 1.42 1.60 0.08 0.90 0.53 0.29
Meal size, kg DM 1.81 1.69 1.76 1.93 0.10 0.87 0.34 0.14
Meal length, minutes 26.4 25.0 25.3 26.7 1.11 0.56 0.80 0.19
Table 3. Milk production and composition responses to yeast culture-enzymatically hydrolyzed yeast (YC-EHY) 
supplementation during the experimental period
Treatment (YC-EHY dose/day) P-value







Milk yield, kg/day 45.3 42.6 47.8 46.7 2.53 0.90 0.39 0.72
Milk fat, % 4.11 4.38 4.33 4.17 0.13 0.20 0.80 0.09
Milk protein, % 2.99 2.89 3.04 3.12 0.07 0.76 0.08 0.17
Milk lactose, % 4.77 4.74 4.84 4.85 0.05 0.45 0.10 0.67
Milk urea nitrogen, mg/dL 13.3 14.1 13.4 13.9 0.63 0.44 0.65 0.81
Fat yield, kg/day 1.81 1.82 2.02 1.90 0.09 0.32 0.24 0.46
Protein yield, kg/day 1.34 1.21 1.42 1.42 0.08 0.86 0.17 0.42
Lactose yield, kg/day 2.16 2.03 2.32 2.26 0.13 0.78 0.30 0.79
Energy utilization efficiency1, % 74.9 79.5 82.6 81.5 3.1 0.08 0.11 0.36









































30 g 60 g 90 g
A
B
0 g 30 g 60 g 90 g
day 7
day 21
Figure 1. Antibody responses to yeast culture with enzymatically hydrolyzed yeast (YC-
EHY) supplemented to dairy cows at 0, 30, 60, or 90 g/day from 21 days before expected 
parturition to 42 days after parturition. (A) Plasma concentrations of anti-ovalbumin IgG 
collected on days -21, -14, and 21 relative to calving. Cows were challenged on days -21,  
-7, and 14 with ovalbumin. There was a tendency for linear dose effect (P = 0.06) and a  
day effect (P < 0.01) but no yeast product vs. control (P = 0.41) or quadratic dose  
(P = 0.50) effects. A treatment × day (P < 0.01) effect was detected, reflecting that yeast 
product linearly increased (P < 0.01) anti-ovalbumin IgG on day 21. (B) Concentrations of 
IgA in fecal samples collected on days 7 and 21 relative to calving. There was a significant 
quadratic dose effect (P = 0.03), but no yeast product vs. control (P = 0.16), linear dose  
(P = 0.73), day (P = 0.61), or treatment × day (P = 0.42) effects.
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Milking Time During Periods of Heat Stress:  
Part of the Solution or Part of the Problem?
L. Rocha, L. Hulbert, F. Scortegagna, B. Voelz, and L. Mendonça
Summary
Milking time may be a stressful event for lactating dairy cows during summer. Increases 
in body temperatures because of crowding in the milk parlor holding pen may contrib-
ute to increased heat stress. The objective of this extension project was to evaluate the 
effectiveness of heat stress abatement in milking facilities from two Kansas commercial 
dairies. Vaginal temperatures at milking were lower than vaginal temperatures before 
milking in one of the dairies. The lower vaginal temperatures at milking, however, were 
not observed in the other dairy at all milkings, likely because of differences in efficacy 
of heat abatement strategies. Milking facilities may be one of the factors to aggravate or 
alleviate heat stress in lactating dairy cows during summer.
Key words: dairy cattle, heat stress, milking parlor, cooling
Introduction
Heat stress has a tremendous economic impact in the dairy industry worldwide. A 2003 
analysis estimated an annual loss of $897 million for the U.S. dairy industry due to heat 
stress. Decreased milk production, low reproductive efficiency, and increased mortality 
are the main causes of economic loss to dairy producers that have herds affected by heat 
stress.
Strategies to cool lactating dairy cows have been the focus of several research studies. 
The use of fans and sprinkler systems may effectively reduce body core temperature 
during summer heat stress. The use of evaporative cooling systems in the milk parlor 
holding pen is highly recommended because the holding pen is the location where cows 
are crowded, which greatly increases the risk of heat stress because of increased body 
temperatures. Cooling cows in the holding pen is considered a top priority when dairy 
producers strive to alleviate heat stress in lactating dairy cows. Although the holding 
pen may be perceived as a contributor to heat stress of lactating dairy cows, it also may 
be considered the area where good evaporative heat loss can be achieved by investing 
resources for an optimal ambient condition. The purpose of this extension project was 
to compare the effectiveness of milking facilities to achieve cow cooling in two commer-
cial dairies.
Experimental Procedures
Two commercial dairies located in Southwest Kansas were used in this study. Cows that 
met the following criteria were eligible to be used in the study: 70 to 100 days in milk, 
non-pregnant, and average daily milk production of 70 to 140 lb. Six lactating Holstein 
cows from second- (2nd) and third-lactation (3rd) cohorts were randomly selected from 
each dairy, and vaginal temperature was collected every 5 minutes for 5 consecutive days 
(August 15 through August 19, 2014). Blank CIDR inserts and calibrated iButton tem-
perature loggers (DS1922L, Embedded Data Systems, Lawrenceburg, KY) were used to 
collect vaginal temperature. During the study period, evaporative cooling systems were 
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used in the holding pen. At site A, cows were housed in free-stall barns equipped with 
fans and sprinklers, with exercise lots adjoining the free-stall barns, and at site B, cows 
were housed in dry lots with shade in the lounging area. Cows were milked thrice daily 
at site A and twice daily at site B. The time of each milking was collected from a parlor 
management software program (DairyPlan C21, GEA Farm Technologies, Naperville, 
IL). Ambient temperature and relative humidity data were collected from the mete-
orological station nearest to the dairies. Data were analyzed by ANOVA for repeated 
measures using the HPMIXED procedure of SAS, or by ANOVA using the GLM 
procedure of SAS. 
Results and Discussion
Three cows lost the temperature loggers and were removed from the study. Days in milk 
and daily milk yield of cows used in the study are outlined in Table 1. Temperature, hu-
midity, and temperature-humidity index (THI) during the study period are outlined in 
Figure 1. The average THI during the study period was 86.5 ± 0.54. Cows were under 
conditions of heat stress during the entire period of the study.
There was no (P = 0.54) difference in vaginal temperatures of 2nd-lactation cows from 
sites A and B (Figure 2A). Third lactation cows from site A had higher (P < 0.01) vagi-
nal temperatures compared with 3rd-lactation cows from site B (Figure 2B). Interest-
ingly, at site B, 2nd-lactation cows had higher (P = 0.05) temperatures than 3rd-lactation 
cows (Figure 3B). No difference was detected (P = 0.51) in vaginal temperatures be-
tween lactations at site A (Figure 3A). Other studies have shown differences in vaginal 
temperatures between primiparous and multiparous cows; however, to our knowledge, 
no research study has compared vaginal temperatures of 2nd- and 3rd-lactation cows. 
Although one could hypothesize that 3rd-lactation cows have higher body temperatures 
during early lactation compared with 2nd-lactation cows because of higher peak milk 
yield, heat dissipation of cows from the 2nd- and 3rd-lactation may be different. Body 
size and surface area may influence heat dissipation, and, consequently, affect body core 
temperature.
Vaginal temperatures of 2nd- and 3rd-lactation cows from site B were 0.7–0.9°F lower 
at milking time than temperatures 3 hours before milking (Table 3). At site A, this dif-
ference was not detected for all milkings (Table 2); lower temperatures at milking time 
were observed only during the first milking shift for 2nd-lactation cows. Third-lactation 
cows had lower vaginal temperatures at milking compared with 3 hours before milk-
ing in the first and second milking shift. This difference was not observed for the third 
milking shift. At site B, vaginal temperatures of cows 3 hours after milking were lower 
compared with vaginal temperatures 3 hours before milking, except for 2nd-lactation 
cows in the first milking shift. This result suggests that milking time for cows in site B 
was beneficial to alleviate heat stress. On the other hand, the same benefit was not ob-
served for cows in site A. At site A, the lower temperature after milking, compared with 
before milking, was observed only in the first milking shift. In the second milking shift, 
cows had higher temperatures after milking. In the third shift, there was no change in 
temperature; cows experienced significant heat stress before, during, and after milking 
because vaginal temperatures were >103.5°F.
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We speculate that facilities (holding pen and parlor) at site B cooled cows more effi-
ciently than the facilities at site A. Various factors may have influenced the effectiveness 
of each dairy to cool cows at the holding pen and parlor. Cows at site B were housed 
in larger groups than cows at site A, which influenced the amount of time spent in the 
holding pen. In addition, parlor efficiency was different between sites; site A had a more 
rapid parlor turnover. Thus, time spent in the holding pen and parlor may have influ-
enced the efficiency of the facilities to cool cows. 
In conclusion, milking time during summer may positively or negatively affect vaginal 
temperatures of lactating cows. Dairies should evaluate the efficacy of cooling systems 
and ventilation in the holding pen and parlor to maximize cow cooling during milking 
time. Moreover, vaginal temperature loggers attached to blank CIDR inserts may be 
used as an assessment tool to evaluate heat stress at milking time.
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Table 1. Milk yield and days in milk of cows used in the study (mean ± SE)
Site A Site B P-value
Item 2nd lactation 3rd lactation 2nd lactation 3rd lactation Lactation Site
Lactation 
× site
Milk yield (lb/day) 103.6 ± 4.14 111.5 ± 4.63 97.0 ± 3.78 113.2 ± 3.78 < 0.01 0.56 0.33
Days in milk 81.0 ± 4.09 85.5 ± 4.58 87.2 ± 3.74 88.3 ± 3.74 0.49 0.28 0.69
Table 2. Vaginal temperatures of cows from 2nd and 3rd lactation at site A (mean ± SE)
Vaginal temperature (°F)
Item 2nd lactation 3rd lactation
First milking shift 3 hours before milking 103.3 ± 0.15a 103.7 ± 0.20a
Milking 102.5 ± 0.15b 103.1 ± 0.19b
3 hours after milking 102.8 ± 0.15b 102.3 ± 0.19c
Second milking shift 3 hours before milking 102.3 ± 0.15a 102.3 ± 0.16a
Milking 102.3 ± 0.15a 101.8 ± 0.15b
3 hours after milking 103.3 ± 0.15b 102.8 ± 0.15c
Third milking shift 3 hours before milking 103.6 ± 0.20 103.6 ± 0.20
Milking 103.8 ± 0.20 103.7 ± 0.20
3 hours after milking 103.7 ± 0.20 103.7 ± 0.20
a,b,c Values within a column with different superscripts differ (P < 0.01).
Table 3. Vaginal temperatures of cows from 2nd and 3rd lactation at site B (mean ± SE)
Vaginal temperature (°F)
Item 2nd lactation 3rd lactation
First milking shift 3 hours before milking 101.9 ± 0.18a 101.9 ± 0.10a
Milking 101.1 ± 0.18b 101.2 ± 0.10b
3 hours after milking 101.8 ± 0.18a 101.3 ± 0.11b
Second milking shift 3 hours before milking 103.5 ± 0.18a 103.5 ± 0.15a
Milking 102.6 ± 0.18b 102.7 ± 0.15b
3 hours after milking 102.8 ± 0.18b 102.5 ± 0.15b





































































































































Figure 1. Temperature, relative humidity, and temperature-relative humidity index (THI) 






















































































































































































































































Figure 2. (A) Vaginal temperatures of 2nd-lactation cows from sites A and B. Site was not 
associated with temperature (P = 0.54), but the interaction between site and time of the 
day (P < 0.01) was associated with vaginal temperature; SEM = 0.19. Cows were milked at 
site A at approximately 1:30 a.m., 10:00 a.m., and 6:00 p.m. Cows were milked at site B 
at approximately 7:45 a.m. and 7:45 p.m. (B) Vaginal temperatures of 3rd-lactation cows 
from sites A and B. Site and the interaction between site and time of the day were  
(P < 0.01) associated with vaginal temperature; SEM = 0.10. Cows were milked at site A at 
approximately 1:30 a.m., 10:00 a.m., and 6:00 p.m. Cows were milked at site B at approxi-

























































































































































































































































Figure 3. (A) Association between lactation number and vaginal temperature at site A. 
Lactation number was not (P = 0.51) associated with vaginal temperature, but the interac-
tion between lactation number and time of the day was (P < 0.01) associated with vaginal 
temperature; SEM = 0.15. (B) Association between lactation number and vaginal tem-
perature at site B. Lactation number and the interaction between lactation number and 
time of the day were (P < 0.05) associated with vaginal temperature; SEM = 0.16.
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Luteolysis and Pregnancy Outcomes after Change 
in Dose Delivery of Prostaglandin F2α in a 5-day 
Timed Artificial Insemination Program  
in Dairy Cows
J. S. Stevenson, S. L. Pulley, and S. L. Hill
Summary
Three experiments were conducted to determine if a larger dose of prostaglandin F2α 
(PG) administered on day 6 of a 5-day Ovsynch timed artificial insemination (AI) 
program would induce regression of the corpus luteum to facilitate AI and pregnancy 
outcomes similar to a traditional 5-day program with two doses of PG. When apply-
ing a 5-day program, cows that ovulate in response to the first GnRH injection have a 
new corpus luteum (CL) that is 2 days younger when PG is administered in a 5- versus 
7-day program. To regress successfully the younger CL, a second injection of PG must 
be given 24 hours after the first PG injection to prevent reduced pregnancy rate after 
the timed AI. These experiments demonstrated that administering 50 mg PG (10 mL 
Lutalyse) on day 6 produced luteolysis as efficiently as 25 mg PG (5 mL Lutalyse) ad-
ministered on days 5 and 6 when the cut point for progesterone was 1 ng/mL 72 hours 
after the first PG injection or 48 hours after the larger PG dose. In contrast, when the 
cut point was 0.5 ng/mL, the larger dose of PG was less effective. Pregnancy outcomes 
in cows did not differ between treatment doses except in one herd (Exp. 3). Although 
pregnancy outcomes were reduced only in one herd with the larger PG dose, this dif-
ference may be confounded with the earlier injection of the second GnRH injection 16 
hours before timed AI, rather than failure of luteolysis in response to the larger dose of 
PG. Delaying the timing of AI, injection of the second GnRH, or both may be war-
ranted to allow sufficient time for progesterone to decrease to basal concentrations in 
response to a larger dose of PG on day 6 to prevent a reduction in fertility.
Key words: luteal tissue, luteolysis, ovulation, progesterone, pregnancy rate
Introduction
Most timed AI (TAI) programs apply a combination of GnRH and prostaglandin F2α 
(PG) to control follicular wave initiation, ovulation, and corpus luteum (CL) regression 
(luteolysis) in dairy herds before first or repeat AI. These programs generally consist of 
injecting GnRH (day 0), a standard 25-mg dose of PG on days 5 and 6 (5-day program) 
or a single dose of PG on day 7 (7-day program), GnRH at 56 hours (Ovsynch-56) or 
72 hours (CO-Synch-72) after PG with TAI administered on day 8 (5-day program) or 
day 10 (7-day program). Unless PG is administered on days 5 and 6 in a 5-day program, 
luteolysis fails to occur in a proportion of cows that formed a new CL after GnRH 
administration on day 0.
A recent report in nonlactating cows modified the 5-day program by applying a larger 
dose (250% of normal) of a PG analog on day 6 and compared that with standard doses 
of PG on days 5 and 6. Results indicated that the larger dose of PG on day 6 (which 
required less animal handling) produced luteolytic outcomes and final preovulatory fol-
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licle diameter similar to the standard doses of PG on days 5 and 6. In a study consisting 
of 2 experiments conducted in lactating dairy cows, estrous cycles were presynchronized 
before a 5-d Ovsynch program to test whether a single large dose (200% of control) of 
either Estrumate or cloprostenol (1 mg) or Lutalyse or dinoprost (50 mg) administered 
on day 5 would produce acceptable rates of luteolysis, pregnancy, or both compared 
with two standard split doses (0.5 or 25 mg, respectively) administered on days 5 and 6. 
In the first experiment, cows were treated with 0.5 mg cloprostenol on days 5 and 6 
(d 0 = GnRH-1 as in Figure 1) compared with 1 mg cloprostenol (double dose) on 
day 5. More luteolytic failures occurred, and pregnancy outcomes were reduced by as 
much as one-third in cows receiving the 1-mg dose of cloprostenol in the first experi-
ment. In the second experiment of similar design, a 50-mg dose of dinoprost (10 mL 
Lutalyse) administered on day 5 resulted in reduced pregnancy outcomes compared 
with the standard 25-mg doses administered on days 5 and 6. In contrast, increasing 
the dose of cloprostenol from 0.5 to 0.75 mg (2 to 3 mL) on day 7 of a 7-day program 
increased luteal regression in multiparous, but not in primiparous cows, resulting in 
improved pregnancy outcomes at 39 days after AI.
We hypothesized that administering 50 mg of PG to lactating dairy cows on day 6 
would produce similar rates of luteolysis as measured by decreased CL tissue area and 
serum progesterone without compromising pregnancy outcomes. Our objectives were 
to: (1) determine the effect of the standard control dose of PG on days 5 and 6 with 
a single larger (200% of control) dose of PG on day 6 in lactating dairy cows before 
first postpartum AI (Experiment 1) on luteal tissue area and progesterone concen-
trations and before repeat services on progesterone concentrations (Experiment 2); 




Estrous cycles were presynchronized (GnRH [2 mL Factrel, Pfizer Animal Health, 
Madison, NJ] 7 days before administration of 25 mg of PG [5 mL Lutalyse, Pfizer 
Animal Health]) in 61 lactating Holstein cows (18 primiparous and 43 multiparous). 
Eleven days later, cows were enrolled randomly within parity in a 5-day Ovsynch-72 
program (62 to 71 DIM) and treatments were administered as illustrated in Figure 1 
(control cows [25-mg dose of PG on days 5 and 6; n = 31] and treated cows [single 50-
mg dose of PG on day 6; n = 30]).
On day 0, follicles and original CL were mapped and measured by transrectal ultra-
sonography (5.0 MHz linear-array transducer, Aloka 500V, Corometrics Medical 
Systems, Inc., Wallingford, CT). On days 5 through 9, ovarian follicles, new GnRH-in-
duced CL, and original CL were measured. The largest ovarian follicle on day 8 was 
traced back to its first appearance to determine the putative preovulatory follicle diam-
eter. Spherical cavity-free area of luteal structures was calculated. Luteolysis was defined 
to occur when concentrations of progesterone were ≥1 ng/mL on day 5 and <1 ng/
mL on day 8. Blood serum was assayed by radioimmunoassay for progesterone in both 
experiments. Assay sensitivity was 1.9 ± 0.5 pg/mL. Inter- and intra-assay coefficients of 
variation for 4 assays were 6.5 and 7.9%, respectively.
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Pregnancy was diagnosed by transrectal ultrasonography on day 32 after TAI. A posi-
tive pregnancy outcome required presence of anechoic uterine fluid and a CL ≥ 25 mm 
in diameter or anechoic uterine fluid and presence of an embryo with a heartbeat.
Experiment 2
Cows diagnosed not pregnant to a previous AI were treated with GnRH on day 0 and 
assigned randomly to the same two treatments as described in Exp. 1 (Figure 1). Blood 
was collected on days 0, 5, 6, and 8. Only data from 63 cows having serum progesterone 
≥1 ng/mL on day 5 were analyzed. Concentrations of progesterone and occurrence of 
luteolysis were analyzed as in Exp. 1.
Experiment 3
Weekly clusters of lactating dairy cows were enrolled in two treatments (Figure 2) 
during an entire calendar year as part of a 5-day timed AI Resynch-Ovsynch program 
(GnRH 5 days before [day 0; GnRH-1] and 56 [p.m. on day 7; GnRH-2] or 72 hours 
[day 8; GnRH-2] after PG with timed AI on day 8). Enrollment occurred on the same 
day (day 0) as a negative pregnancy diagnosis (30 to 36 days after last AI in herd 1 or 
days 34 to 40 in herd 2). Control cows received a 25-mg dose of PG (5 mL Lutalyse) 
on days 5 and 6 (2 × 25), and treated cows received one single 50-mg dose of PG on 
day 6 (1 × 50; 10 mL Lutalyse). Cows in herd 1 were blocked by parity and assigned 
randomly to treatments: 2 × 25 (n = 142) or 1 × 50 (n = 140). In herd 2, even-tagged 
cows received the 2 × 25 (n = 422) treatment, and odd-tagged cows received 1 × 50 (n 
= 450) treatment. Body condition scores were assessed (1 = thin and 5 = obese) either 
weekly in herd 1 or monthly in herd 2.
In herd 1, ovaries were scanned by transrectal ultrasonography to determine the num-
ber of CL and number of ovarian follicles ≥10 mm in diameter on day 0. Subsequent 
to treatment and timed AI, pregnancy was diagnosed by transrectal ultrasonography 
30 to 36 days after AI. In herd 2, pregnancy was determined by palpation per rectum of 
the uterus and its contents on days 34 to 40 after AI. In both herds, a second pregnancy 
confirmation was conducted between 60 and 70 days post-AI.
In herd 1, blood was collected on days 0, 5, 6, and 8. Blood serum was assayed for 
progesterone by radioimmunoassay. Assay sensitivity was 1.3 ± 0.5 pg/mL. Inter- and 
intra-assay coefficients of variation for 5 assays were 8.2 and 4.8%, respectively.
Results and Discussion
Experiment 1
On day 0, 51 of 61 cows had at least 1 CL and 15 had 2 or more CL, whereas 10 cows 
(5 cows per treatment) had no CL. On day 5, 34 of 61 cows had least 1 new CL, and 5 
cows had 2 or more new CL. Therefore, the ovulation response to GnRH on day 0 was 
31 of 61 (50.8%). Numbers of cows with 1, 2, or ≥ 3 total CL (original plus new CL) 
on day 5 were as follows: 1 CL: 12 vs. 13; 2 CL: 13 vs. 14; and ≥3 or more CL: 6 vs. 3 
for control and 50-mg cows, respectively.
Original luteal tissue area was similar on day 5 but differed between treatments on day 
6 (P = 0.001) and day 7 (P = 0.009) and tended (P = 0.068) to be less on day 8 for the 
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control. In contrast, no differences were detected between treatments for GnRH-in-
duced luteal tissue area.
Concentrations of progesterone differed (P = 0.001) only on day 6 between treatments 
(Figure 3; upper panel). Luteolysis occurred in all 31 controls but failed to occur in 2 of 
30 (6.7%) 50-mg cows in which no CL were present on day 0, but 1 or 3 new GnRH-
induced CL were present on day 5 in the 2 cows with luteolytic failure.
Pregnancy outcomes were 12 of 30 (40%) for control cows and 15 of 30 (50%) for 50-
mg cows. One control cow was culled before pregnancy was determined.
Experiment 2
Concentrations of progesterone differed between treatments only on day 6 (Figure 
3; lower panel). Luteolysis occurred in all 29, 50-mg cows but failed to occur in 2 of 
34 (5.9%) controls. Pregnancy outcomes at day 32 after TAI were 17 of 33 (52%) for 
control cows and 13 of 29 (45%) for 50-mg cows. One control cow was culled before 
pregnancy diagnosis.
Experiment 3
Progesterone. Concentrations of progesterone differed (P < 0.01) between treatments 
on day 6 and 8. More (P < 0.05) 1 × 50 than 2 × 25 cows had concentrations of proges-
terone ≥1 ng/mL on day 6, but similar proportions of cows in each treatment had low 
(<1 ng/mL) concentrations by day 8 (Figure 4). Progesterone also differed among cycle 
statuses on day 0 and 5, but not between treatments, which had not yet been adminis-
tered. Both anestrous and new-CL cows in both treatments had low concentrations on 
day 0 and differed (P < 0.05) from those of early- and late-cycle cows, which differed  
(P < 0.05) from one another.
On day 5, concentrations of progesterone were near baseline in late-cycle cows, sug-
gesting early spontaneous luteolysis before treatment on days 5 or 6, whereas concen-
trations in new CL cows increased (P < 0.01) by 7.4 to 10.3 times from day 0 to 5, 
indicating ovulation occurred after GnRH-1 on day 0. Concentrations of progesterone 
in early-cycle cows were elevated on both days 0 and 5 (Figure 4). Relative differences 
among cycle statuses for cows in both treatments on day 6 were consistent with what 
was observed on day 5, except on day 6, new-CL and early-cycle cows no longer differed 
from one another. By day 8, concentrations of progesterone did not differ among cycle 
statuses for cows in either treatment.
Luteolysis. Cows treated with 50 mg PG on day 6 were more (P = 0.003) likely to have 
incomplete luteolysis when the cut point on day 8 was <0.5 ng/mL. In contrast, when 
the cut point was <1 ng/mL, no difference was detected between treatments (Table 1). 
Luteolysis in cows most likely to fail to respond to PG (early-cycle and new-CL cows) 
did not differ between early-cycle and new-CL cows (86.5 vs. 83.0%) for the <0.5 ng/
mL cut point or for the <1 ng/mL cut point (97.4 vs. 100%), respectively.
Cycle status within treatment reflected the overall treatment effects for luteolysis. 
Although treatment differences were not detected for early-cycle cows between treat-
ments, luteolysis in the 2 × 25 vs. 1 × 50 cows reflected the overall treatment differences 
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in Table 1 at the <0.5 ng/mL cut point (94.8 vs. 78.2%; P = 0.495) and at the  
<1 ng/mL cut point (87.5 vs. 79.3%; P = 0.191), respectively. Defined luteolysis was 
not affected by either BCS or number of follicles >10 mm assessed on day 0.
In response to treatment on day 5, concentrations of progesterone on day 6 decreased 
in 2 × 25 cows in response to the first of two 25-mg injections and differed (P = 0.001) 
from those in the 50-mg treatment for early-cycle and new-CL cows only, whereas no 
treatment differences were detected in late-cycle and anestrous cows (Figure 4). Al-
though concentrations of progesterone had decreased further by day 8, difference (P = 
0.001) between treatments existed only for early-cycle cows, indicating that early-cycle 
cows also may have had additional new luteal tissue in the form of a new CL that was 
resistant to the luteolytic effects of PG.
Pregnancy Outcomes. Pregnancy per AI at the first and second diagnosis period was re-
duced in anestrous and late-cycle cows compared with early-cycle and new-CL cows in 
both treatments for cows in herd 1. Pregnancy per AI (30 to 36 days post-AI) for cows 
in herd 1 with luteolysis defined at the cut point of <0.5 ng/mL did not differ between 
2 × 25 vs. 1 × 50 treatments (48.5% [n = 101] vs. 37.5% [n = 80]) or at the cut point of 
<1 ng/mL (46.3% [n = 108] vs. 41.0% [n = 100]), respectively. Neither parity  
(P > 0.50) nor BCS had any effect (P > 0.31) on pregnancy per AI in herd 1.
Pregnancy outcomes at 30 to 40 day differed (P < 0.001) among herds, but the 1 × 50 
cows tended (P = 0.071) to have lesser fertility only in herd 2 (Table 2). This treatment 
difference in herd 2 was confirmed (P = 0.036) at the later pregnancy diagnosis in herd 
2 (Table 2).
We conclude that one large dose (50 mg PG) administered on day 6 is luteolytic (re-
gressed the CL) using a cut point of 1 ng/mL, which is consistent with earlier reports in 
non-lactating and lactating cows (Exp. 1 and 2), but not so when a more conservative 
cut point of 0.5 ng/mL was applied (Exp. 3). Although progesterone may eventually 
decrease to sufficient concentrations (complete functional luteolysis) with time, it may 
not achieve sufficiently basal concentrations in some cows to prevent reduced preg-
nancy outcomes, particularly those defined as early-cycle, having a new CL on day 0, or 
both. Although pregnancy outcomes were reduced only in herd 2 with 1 × 50 treat-
ment compared with herd 1, this difference may be confounded with the earlier injec-
tion of GnRH-2 16 hours before timed AI in herd 2 rather than failure of luteolysis to 
the larger dose of PG. Delaying the timing of AI, injection of GnRH-2, or both, may be 
warranted to allow sufficient time for progesterone to decrease to basal concentrations 
in response to a larger dose of PG on day 6 to prevent a reduction in conception.
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Table 1. Luteolysis at 2 different cut points for cows treated with 2 × 25 or 1 × 50 mg of 
PGF2α in herd 1 (Exp. 3)
1
Treatment2 Luteolysis (%) Odds ratio
95% confidence 
interval P-value
------------------------------------------------ < 0.5 ng/mL ------------------------------------------------
2 x 25 93.3 Referent
1 x 50 78.5 0.264 0.108 – 0.645 0.003
------------------------------------------------ < 1 ng/mL -------------------------------------------------
2 x 25 100.0 Referent
1 x 50 96.3 < 0.1 . . . 0.947
1 Progesterone ≥1 ng/mL on day 5 and either <0.5 or <1 ng/mL 72 hours later on day 8.
2 Cows received either 25 mg PGF2a (PG) on days 5 and 6 or a 50 mg PG on day 6 as part of a 5-day Resynch-
Ovsynch program (d 0 = GnRH-1).
Table 2. Pregnancy per AI in both herds at 30 to 40 and 60 to 70 days post-AI (Exp. 3)
Treatment1
Stage of pregnancy, days 2 × 25 1 × 50 P-value
30 to 40 % (n)
Herd 1 37.2 (139) 33.3 (134) 0.517
Herd 2 24.7 (422) 19.5 (450) 0.071
60 to 70
Herd 1 31.3 (139) 28.2 (134) 0.608
Herd 2 22.7 (422) 16.9 (450) 0.036
1 Cows received either 25 mg PGF2a (PG) on days 5 and 6 or a 50 mg PG on day 6 as part of a 5-day Resynch-










































Figure 1. Scheme of treatments and measurements for Experiments 1 and 2. In Experi-
ment 1, estrous cycles were presynchronized by injecting 100 μg GnRH and 25 mg of 
PG beginning between 62 and 71 days in milk. Cows were assigned randomly to receive 
either 25-mg doses of PG on days 5 and 6 or a 50-mg dose of PG on day 6. Ovarian struc-
tures were measured by transrectal ultrasonography (S) and mapped on day 0 and days 5 
through 9. Both original CL on day 0 and GnRH-induced CL identified on day 5 were 
measured and monitored for diameter and luteal area (CL cavity area was deducted from 
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Figure 2. Experiment 3 treatment schemes in two herds. In herd 1, cows were assigned ran-
domly to receive either 25 mg PGF2a (PG) on days 5 and 6 or a 50-mg dose of PG on day 
6. Blood samples were collected on days 0, 5, 6, and 8 to measure progesterone. In herd 2, 
even-tagged cows received 25 mg PG on days 5 and 6, and odd-tagged cows received 50 mg 
PG on day 6. The second GnRH (GnRH-2) injection was administered on the afternoon 
of day 7, and timed AI (TAI) occurred on the morning of day 8 in herd 2, but TAI oc-
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Figure 3. Concentrations of progesterone in control (25-mg doses of PG on days 5 and 6) 
and treated cows (50 mg of PG only on day 6) for cows in Exp. 1 (upper panel) and Exp. 2 
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Figure 4. Concentrations of progesterone on days 0, 5, 6, and 8 for cows treated with 
either 25 mg PGF2α (PG) on days 5 and 6 (2 × 25) or 50 mg PG on day 6 (1 × 50) in Exp. 3. 
Cows were classified by concentrations of progesterone on day 0 and 5: (1) anestrus  
(<1 ng/mL on both days); (2) early cycle (≥1 ng/mL on both days); (3) late cycle  
(≥1 ng/mL on day 0 and <1 ng/mL on day 50; and (4) new CL (<1 ng/mL on day 0 and  
≥1 ng/mL on day 5). a, b Means within treatment differed (P < 0.05) among cycle statuses.
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Effects of Postpartum Treatment with Non-
Steroidal Anti-Inflammatory Drugs on Milk 
Production and Culling Risk in Dairy Cattle
 
A. Carpenter, C. Ylioja, C. Vargas, L. Mamedova, L. Mendonça, J. Coetzee1, 
L. Hollis, R. Gehring, B. Bradford
Summary
Inflammation during early lactation is common in dairy cattle, and a high degree of 
inflammation during this time has recently been associated with both lower productiv-
ity and greater risk of disease during that lactation. Early lactation treatments with two 
non-steroidal anti-inflammatory drugs were compared with a placebo treatment to 
evaluate effects on whole-lactation productivity and retention in the herd. Both meloxi-
cam and sodium salicylate increased whole-lactation milk and milk protein yields by 6 
to 9%, despite being administered for only 1 or 3 days in early lactation, respectively. 
In addition, meloxicam treatment tended to decrease the risk of cows leaving the herd 
during the lactation. These results indicate that postpartum inflammatory signals have 
long-lasting effects on lactation in dairy cattle.
Key words: transition dairy cow, inflammation, non-steroidal anti-inflammatory drug
Introduction
A growing body of research indicates that systemic metabolic inflammation is elevated 
in dairy cows at parturition and that this inflammation may play a role in the develop-
ment of metabolic disorders during the transition period. Furthermore, inflammation 
has been linked to negative production outcomes. In one study, authors reported that 
cows in the highest quartile of inflammation had decreased milk production compared 
with their counterparts (30.9 kg/day vs. 24.4 kg/day in cows with low inflammation). 
In previous work at Kansas State, we administered dairy cattle with the non-steroidal 
anti-inflammatory drug (NSAID) sodium salicylate (SS) via drinking water in the week 
following calving in an attempt to prevent inflammation. Despite the fact that transi-
tion disorders were rare in either group, treatment with SS was associated with elevated 
whole-lactation milk production in older cows. Cows in their third or later lactation 
that received SS produced 21% more milk over a 305-day lactation. 
Meloxicam is another drug in the NSAID class. Previous research in lactating cattle has 
focused on its use during clinical mastitis or following assisted calving, but meloxicam’s 
effects on milk production in normal postpartum dairy cattle have not yet been investi-
gated. Considering the effects of SS on production, it is likely that meloxicam may also 
have beneficial effects on lactation. Therefore, the objective of this study was to deter-
mine if SS or meloxicam would have similar effects on whole-lactation productivity of 
dairy cows on a commercial dairy farm. 




Multiparous cows (n = 51 per treatment) from a commercial dairy were enrolled in the 
study 12 to 36 hours after calving. Cows receiving SS treatment (SS) received a placebo 
bolus on day 1 of treatment and an oral drench containing 125/g/day of SS in 375 mL 
of water for 3 consecutive days beginning on day 1 of treatment. Meloxicam-treated 
cows (M) received 675 mg of meloxicam as a bolus on day 1 of treatment in combina-
tion with 3 consecutive daily drenches of 375 mL of water. Control animals (CON) 
received a placebo bolus on day 1 and water drenches. Treatments were blocked by 
mastitis at parturition (CON = 1, M = 2, SS = 2), breed (CON = 6, M = 6, SS = 4 
crossbreds; all other cows were Holsteins), dystocia (CON = 5, M = 5, SS = 6), and 
twin births (CON = 4, M = 4, SS = 3). Dystocia was defined as a calving difficulty score 
of 3 or greater.
Whole-lactation milk yield data were analyzed with a covariate of predicted transmit-
ting ability for milk production, the fixed effects of block, parity, treatment, week, and 
treatment × week interaction, and the random effect of cow. The model accounted for 
repeated measures over time with an autoregressive covariance structure. Treatment 
contrasts were evaluated using the Tukey test with significance declared at P < 0.05. Re-
moval rate from the herd and pregnancy rate were evaluated by Cox regression propor-
tional hazard analysis, and disease incidences were tested by Fisher’s exact test.
Results
Milk production responses to treatment were evaluated using two different data sourc-
es. Adjusted 305-day mature equivalent yields of milk, fat, and protein through DHIA 
testing revealed significant whole-lactation milk and protein responses to both M and 
SS treatments, representing 6 to 9% advantages for the NSAID treatments (Table 1). 
Numerical differences in fat yield were of similar magnitude (5 to 6%) but were not 
statistically significant. In addition, daily milk yield data from the farm management 
system were analyzed to assess treatment responses over time. The overall treatment 
effect on daily milk production was again significant for both NSAID treatments  
(P < 0.05, Figure 1), with a slightly larger mean response of 10 to 12%. As we observed 
in a previous study with SS, milk yields did not diverge until the second month of 
lactation, but differences in productivity then remained through the end of lactation. 
Despite the increase in productivity, body condition score monitoring throughout 
lactation revealed no differences between treatments (Table 1).
Treatments did not alter pregnancy rate on first service (mean: 23%) and had no impact 
on risk of pregnancy throughout the lactation. However, analysis of retention within 
the herd did reveal a tendency for M to improve retention compared with CON  
(P = 0.06), with SS intermediate (Figure 2). By the end of the lactation, 41% of CON 
cows had left the herd, compared with 31% for SS and only 25% for M. The only culling 
reason that differed between M and C was the code “other disease,” which accounted 
for 8 culls in CON and only 2 in M (P = 0.09); this code was used for a variety of con-
ditions, including key transition problems such as ketosis and respiratory disease.
Discussion
These results represent the fourth study demonstrating that short-term early lactation 
treatment with SS can enhance peak milk yield and the first to demonstrate similar re-
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sults with M. More importantly, this study is the first such finding with a relatively large 
sample size and with daily milk yield data to allow for accurate analysis of the lactation 
curve following treatment.
The fact that early lactation treatment (for as little as 1 day) with an anti-inflammatory 
agent can influence milk production for at least 10 months is fascinating and is not 
easily explainable. Our group is currently conducting research to explore the possibility 
that interrupting early lactation inflammation programs the mammary gland to allow 
for increased expression of milk synthesis genes as lactation proceeds.
Equally exciting is the possibility that M treatment can improve health in early lactation 
to limit the culling rate. Our sample size for this outcome was minimal, however, and 
our findings, which were of marginal significance, should be considered preliminary. In 
previous work, we carefully evaluated the effects of SS on metabolic health and found 
no evidence of improvement, but the current results seem to hint at a different response 
to M treatment, particularly in the critical first 60 days of lactation. Larger studies 
should help clarify whether these findings are meaningful or not.
Conclusions
Both M and SS increased 305-day milk and protein yields compared with CON with 
no effect on 305-day milk fat. These responses were primarily due to increased peak 
milk yield and sustained differences through late lactation and did not appear until 
the second month of lactation. Furthermore, neither treatment affected body condi-
tion score, and M tended to improve retention in the herd compared with CON. The 
long-term benefits of early lactation NSAID use are surprising and will require further 
research to understand the underlying mechanisms. Although using these approaches 
commercially is not currently legal, ongoing research may allow for nutritional or phar-
maceutical approaches to take advantage of these findings in the future.
Table 1. Whole-lactation (305-day) mature equivalent milk yield and body condition 
score (BCS) responses to early lactation treatment with anti-inflammatory drugs






23,091b 24,707a 25,161a 1,072 0.02
Fat yield (lb) 869 919 913 40 0.13
Protein yield 
(lb)
739b 785a 789a 31 0.03
BCS1 3.24 3.30 3.20 0.12 0.52
1 1 to 5 scale; 1 = thin and 5 = fat.
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Figure 1. Whole-lactation milk yield responses to early lactation treatments. Daily milk 
yield data were summarized by week and evaluated for the entire 44-week lactation. Both 
meloxicam (M) and sodium salicylate (SS) significantly increased daily milk yield by an 
average of 8.7 and 7.5 lb/day, respectively (P < 0.05), compared with the control. Treat-
ment differences were not significant until week 7 of lactation, then remained significant 
or marginally significant (P < 0.10) for most weeks through the end of lactation. 
Days in milk




























Figure 2. Survival analysis of retention in the herd after early lactation treatments. Meloxi-
cam (M) treatment tended to increase retention in the herd compared with the control 
(CON), as assessed by the Wilcoxon Chi-squared test (P = 0.06). Sodium salicylate (SS) 
did not differ from other treatments.
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Preliminary Studies on In Situ Monitoring  
of Lactose Crystallization Using Focused Beam 
Reflectance Measurement
K. Pandalaneni, J.K. Amamcharla 
Summary
Isothermal crystallization of lactose was studied at supersaturated concentrations (w/w) 
of 50%, 55%, and 60% at temperatures 20ºC and 30ºC using an in situ system, focused 
beam reflectance measurement (FBRM), and a refractometer. The FBRM data were 
compared with Brix readings taken over time using a refractometer during isothermal 
crystallization. Chord length distribution obtained from FBRM in the ranges of <50 
µm (fine crystals) and 50 to 300 µm (coarse crystals) were observed and evaluated in re-
lation to the extent of crystallization and rate constant results deduced from the refrac-
tometer measurements. The measured fine crystal counts increased with supersaturated 
concentration and temperature during isothermal crystallization. On the other hand, 
coarse counts were observed to increase with decreasing supersaturated concentration 
and temperature. The total crystal counts (coarse + fine crystals) obtained from FBRM 
increased as the temperature increased at all concentrations. The robustness of FBRM 
in understanding isothermal lactose crystallization at various concentrations and tem-
peratures was successfully evaluated in the study. 
Key words: lactose crystallization, focused beam reflectance measurement
Introduction
Lactose is the most abundant carbohydrate present in milk. It is found in concentra-
tions of 4.4 to 5.2% and is one of the major constituents in infant formulations, dried 
milk, and whey products. Commercial production of lactose involves concentration of 
whey or whey permeate by evaporation followed by batch crystallization. During the 
process, α-lactose crystallizes as tomahawk-shaped crystals. Crystal size distribution and 
lactose yield are the most important criteria to monitor during industrial crystallization 
of lactose and are influenced by the degree of supersaturation, rate of cooling, agitator 
speed, presence of impurities, and viscosity of supersaturated feed material. 
The dairy industry currently is depending on refractometer measurements to follow 
lactose crystallization, but this approach provides no information on crystal size dis-
tribution during crystallization. In situ monitoring of lactose crystallization to meet 
the special requirements of crystal size distribution (CSD) is needed. Focused beam 
reflectance measurement (FBRM) could be used to monitor the CSD and chord length 
distribution (CLD) in situ from supersaturated lactose solution. 
The FBRM uses a monochromatic laser (785 nm) rotating at a constant speed of 2 
meters per second. As particles pass in front of the probe window, light is backscattered 
from the particles to the sapphire window. The duration of the backscatter is measured 
and particle chord length is obtained. Schematic representation of working principle of 
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FBRM is shown in Figure 1. The objective of the present study was to evaluate the ap-
plicability of FBRM for in situ monitoring of the isothermal crystallization of lactose. 
Experimental Procedures
Experimental Design
A 2 × 3 factorial design was used in the study, with temperature and concentration as 
independent variables. Concentrations (50%, 55%, and 60%) w/w were randomly as-
signed to temperatures (20ºC and 30ºC) and resulted in 6 measurements. Experiments 
were conducted randomly and in two replications.   
Preparation of Supersaturated Lactose Solution
Lactose solutions of desired supersaturation were prepared using 99.7% pure alpha 
lactose (Davisco Foods International, Inc., Le Seuer, MN). Desired concentrations of 
lactose (w/w) were obtained by dissolving 250, 275, and 300 g of α-lactose in 250, 225, 
and 200 g of distilled water to prepare 50%, 55%, and 60% (w/w) supersaturated solu-
tions, respectively. The lactose and water mixture was heated to 87±3°C under continu-
ous stirring to dissolve all the crystals. A lid was placed on the beaker to avoid moisture 
loss during heating. After ensuring the dissolution of all the crystals, the supersaturated 
lactose solution was rapidly cooled to the desired experimental temperature (20ºC or 
30ºC) without agitation. 
Isothermal Crystallization of Lactose 
Isothermal lactose crystallization studies were carried out in a batch crystallizer specially 
designed for this work. The FBRM probe (Particle Track E25, Mettler-Toledo Au-
toChem, Inc., Columbus, OH) was immersed in a purpose-built batch crystallizer for 
in situ monitoring of the crystallization process as shown in Figure 2. The batch crystal-
lizer was placed in a temperature-controlled water bath that could maintain a constant 
temperature. An overhead stirrer with a four-bladed propeller (Caframo, Georgian 
Bluffs, Ontario, Canada) was placed in the crystallizer to facilitate stirring. As shown 
in Figure 2, the propeller was maintained at 2.5 cm above the bottom of the beaker 
containing the supersaturated sample. The FBRM in-situ probe was fixed at a height of 
5 cm from the bottom of the beaker and at an angle of 30 ± 5° to the vertical axis of the 
stirrer for all the crystallization experiments.
Crystallization Monitoring Using an FBRM Probe 
Before the start of each experiment, the FBRM probe was cleaned thoroughly with dis-
tilled water to avoid interference from unwanted particles, as suggested by the manufac-
turer. The data from the FBRM probe were acquired using iC FBRM (version 4.3.391, 
Mettler-Toledo) every 3 minutes for the first 60 minutes and every 30 minutes there-
after during isothermal crystallization. Three categories of crystal chord length ranges, 
0.5–50 µm, 50–300 µm, and 300–2,000 µm, were monitored and are designated fine, 
coarse, and large, respectively. 
Determination of Extent of Crystallization and Rate Constant
At regular intervals, an approximately 1 ml of the crystal suspension was removed from 
the crystallizer using a dropper to measure the refractive index of the suspension. The 
refractive index, expressed in terms of °Brix, of lactose solution was measured using a 
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digital refractometer (Reichert Technologies, Depew, NY). A calibration curve was 
used to convert the °Brix reading to actual lactose concentration solution, and refrac-
tometer readings were subsequently used to calculate the mass of crystals and extent 
of crystallization at any time t during isothermal crystallization. Mass of crystals at any 
time t was calculated from the initial lactose concentration C(0) and lactose concentra-
tion C(t) at time t using Equation 1. Water was assumed to represent 5% of the total 





where MCrystal(t) is mass of crystals at given time t, MH2O(0) represents 5% of the total 
mass of lactose crystal, C(0) is initial concentration, and C(t) is concentration at time t. 
The extent of crystallization at time t was calculated using Equation 2 from the mass of 
crystals at time t obtained from Equation 1 and saturation concentration of lactose at 
temperature 20ºC and 30ºC. 
%Y(t) =
MCrystal(t)
X100     (2)
MCrystal(t –›  ∞)
where Y(t) is the extent of crystallization at time t, MCrystal(t) is the mass of crystals 
obtained from Equation 1, and MCrystal(t –›  ∞) is the mass of crystals at lactose solubility 
at experimental temperature.
From the concentration difference ∆C, plotted against time t, it was observed that the 
curve shows best the first-order decay fit. The rate constant can be deduced from plot-
ting Equation 3, the first-order decay equation, where [A0] is the initial concentration 
of lactose solution before crystallization and k is the rate constant. [A] is the concen-
tration difference ∆C, at a given time t, where ∆C = C(t) – C( t  ∞), with C( t  ∞) as 
lactose solubility value at the temperature of interest. 
ln (
[A]
) = –kt     (3)
[A0]
Results and Discussion
Determining Extent of Crystallization and the Rate Constant  
from Brix Values
The extent of crystallization was determined during the isothermal crystallization of 
lactose for 50%, 55%, and 60% concentrations at 20ºC and 30ºC. Figure 3 shows the 
extent of crystallization during isothermal crystallization of lactose for 50%, 55%, and 
60% concentrations at 20ºC and 30°C, respectively. Figure 3 shows that the extent 
of crystallization was higher at 30°C than at 20°C for all concentrations of lactose. 
The time required for isothermal crystallization to reach 90% was 300, 360, and 420 
minutes for 60%, 55%, and 50% lactose solutions, respectively. On the other hand, 
the extent of crystallization at 20°C did not reach 90% even at 630 minutes for all the 
lactose concentrations studied. The extents of crystallization at 30°C were calculated 
to be 93%, 95%, and 96% for 50%, 55%, and 60% solutions, respectively. The extents 
of crystallization at 20°C were calculated to be 80%, 83%, and 86% for 50%, 55%, and 
60% solutions, respectively. 
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Extent of crystallization increased with lactose concentration at a given experimental 
temperature. A maximum extent of crystallization was observed for the 60% supersatu-
rated solution concentration followed by 55% and 50% lactose concentrations at 30ºC. 
A similar trend was observed at 20ºC. 
Rate constants for the isothermal crystallization of lactose at 20°C and 30°C were 
calculated using Equation 3. For calculation purposes, it was assumed that the rate of 
mutarotation proceeded at a higher rate than crystallization of α-lactose. This assump-
tion is based on the fact that mutarotation is not a limiting factor during crystallization 
of lactose.  The rate constants obtained at different concentrations and temperatures 
are shown in Figure 4, which shows that the rate constants were higher at 30°C than at 
20°C for the three lactose concentrations studied. 
Overall, refractometry is a suitable technique to calculate crystal mass throughout lac-
tose crystallization. Another advantage of this technique is that it can be implemented 
easily regardless of crystallizer design; however, refractometer readings do not provide 
information on crystal size distribution. 
Evaluation of FBRM Data
Plots of fine crystal counts (<50µm) obtained from FBRM during the isothermal crys-
tallization of lactose at various temperatures and concentrations against time are shown 
in Figure 5. A steep increase in the fine crystal count was observed during the initial 
phase of crystallization (first 15 minutes) and can be attributed to primary nucleation 
of lactose crystals. These findings were in agreement with the extent of crystallization 
and the rate constant as shown in Figures 3 and 4, respectively. A further increase in 
fine crystal counts after the initial rapid increase was due to secondary nucleation and 
disintegration of lactose crystals. The disintegration of lactose crystals was caused by at-
trition and collisions between crystals and the crystallizer walls and impeller. 
The plot of coarse crystal counts (50–300 µm) obtained from FBRM during isothermal 
crystallization of lactose at various temperatures and concentrations is shown in Figure 
6, which shows a substantial difference between coarse crystal counts of lactose at 30ºC 
and 20ºC. The growth of crystals at 20ºC was also relatively higher than that of the 
lactose crystals obtained at 30ºC. The number of coarse crystals increased as tempera-
ture and supersaturation decreased; in other words, isothermal crystallization at 20°C 
and a concentration of 50% were favored to produce the largest mean-squared crystals 
in the present study. In contrast, the count of fine crystals increased as temperature and 
supersaturation increased. These results suggest that growth of crystals was favorable 
as temperature decreased, whereas an increase in temperature favored nucleation and 
formation of finer crystals. 
Counts of larger particles (300–1,200 µm) were found to be negligible and were not 
included in the analysis. 
Evaluation of Chord Length Distribution
Chord length distributions obtained from FBRM at various time intervals during 
isothermal crystallization of lactose for all the treatments are shown in Figure 7. Crys-
tal counts at 30 minutes at 30ºC were clearly higher than at 20ºC for all supersatu-
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rated concentrations, which supports observations from Figure 5. Total crystal counts 
increased with time for the first 6 to 8 hours and decreased during the last few hours in 
55% and 60% concentrations. At 50% concentration, however, counts were reported to 
increase more at 20ºC than at 30ºC throughout the experiment, which is also apparent 
in Figure 6. A decrease in total crystal counts can be explained as a combination of the 
breakage of crystals and the interference of smaller crystals. A prominent decrease in the 
number of coarse crystals at 30ºC can be explained by the fact that, as the growth and 
density of crystals increases, the probability of the probe detecting particle width rather 
than particle length is high. Impeller speed, apart from enabling active crystallization by 
uniform supersaturation and mass transfer, also causes breakages, which could be an ad-
ditional explanation for a decrease in coarse crystal count as time proceeds and was easy 
to track using FBRM.
Conclusion
The efficiency of FBRM in studying lactose crystallization with respect to operation 
parameters such as concentration and temperature was evaluated. FBRM is a powerful 
tool, and it can be used to follow secondary nucleation as a result of attrition and break-
age apart from chord length distribution and crystal size. The results of this study imply 
that changes in concentration and temperature were well understood in terms of crystal 
size and counts over time using FBRM. The data obtained from FBRM supplements 

























Figure 1. (a) Focused beam reflectance measurement (FBRM) probe design, (b) detection 
of particles by probe using a laser moving at constant velocity, and (c) chord length distri-










Figure 2. Experimental setup for evaluation of lactose crystallization using focused beam 
reflectance measurement (FBRM). 
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Figure 4. Rate constants of different concentrations at 20⁰C and 30⁰C.
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Figure 7. Chord length distributions of crystals obtained from focused beam reflectance 
measurement data at different time periods. (A) 20ºC, 50%; (b) 30ºC, 50%; (c)20ºC, 55%; 
(d) 30ºC, 55%; (e) 20ºC, 60%; (f) 30ºC, 60%.
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